BUSINESS Aurobindo Pharma secures USFDA approval for diabetes drug with estimated market size of $514 million Apr 7, 2026
BUSINESS Aurobindo Pharma receives USFDA approval for Dapagliflozin tablets with market size of $10.2 billion Apr 7, 2026
BUSINESS Alembic Pharmaceuticals receives USFDA approval for Dapagliflozin tablets with US$ 10.487 billion market size Apr 7, 2026